No channels found
  1. Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs

    Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs

    3
  3. BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

    BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

    6
  6. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    16
  7. September 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from Schizophrenia

    September 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from Schizophrenia

    299
  8. Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

    Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

    5
  9. Desperately seeking Medical Expertise (samples.. )

    Desperately seeking Medical Expertise (samples.. )

    24
  10. Learn How This Company is Revolutionizing Pet Care

    Learn How This Company is Revolutionizing Pet Care

  11. Unicycive Therapeutics: Advancing Breakthroughs in Kidney Disease Therapies

    Unicycive Therapeutics: Advancing Breakthroughs in Kidney Disease Therapies

  12. Unicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity in Kidney Disease

    Unicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity in Kidney Disease

  13. Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    3
    0
    6
  15. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    5
  16. Reviva: Providing a Major Breakthrough for Mental Health and Schizophrenia

    Reviva: Providing a Major Breakthrough for Mental Health and Schizophrenia

    8
  17. Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial

    Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial

    7
  18. Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    11
  19. Peptilogics founder Jonathan Steckbeck (Peter Thiel-backed BioTech) Full Interview

    Peptilogics founder Jonathan Steckbeck (Peter Thiel-backed BioTech) Full Interview

    6
  20. HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    10
  21. BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease

    BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease

    1
  22. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    3
  23. In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More

    In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More

    2
  24. Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    2
  25. Loophole in dutch and european legislation

    Loophole in dutch and european legislation

    26
    0
    1.43K
    2